← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-11 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
ADCBiologicstaleSeagen Inc.Phase 2

docetaxel (Taxotere, Taxotere (docetaxel))

Prostatic Neoplasms · Prostatic Neoplasms

#ProstaticNeoplasms#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 22.7%임상시험 1상태 ACTIVE
AntibodystaleQamar KhanPhase 2

trastuzumab (Herceptin, Taxotere, Carboplatin, Herceptin + Pertuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

Tcrx T cell (Tcrx T cell)

Gastric Cancer; Gastroesophageal-junction Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleImmunocore LtdPhase 3

pembrolizumab (Keytruda, Tebentafusp with Pembrolizumab)

Advanced Melanoma · Advanced Melanoma

#AdvancedMelanoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 2

Teclistamab Monotherapy (Teclistamab Monotherapy)

Relapse Multiple Myeloma; Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 2

FDA-approved (Teclistamab, Teclistamab(FDA-approved))

Multiple Myeloma; Cytokine Release Syndrome · FRα

#FR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleChinese SLE Treatment And Resea…Approved

Telitacicept (Telitacicept)

ANCA Associated Vasculitis · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleEric Thompson, M.D.Phase 1

Tetanus Pre-Conditioning (Tetanus Pre-Conditioning)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleEric Thompson, M.D.Phase 1

Tetanus-Diphtheria booster (Tetanus-Diphtheria booster)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleWuhan Bio-Raid Biotechnology Co…Phase 1

Third generation CAR-T cells (Third generation CAR-T cells)

B Cell Lymphoma; Acute Lymphoblastic Leukemia · B Cell Lymphoma

#BCellLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleWuhan Bio-Raid Biotechnology Co…Phase 1

Third-generation anti-CD123 CAR-T cells (Third-generation anti-CD123 CAR-T cells)

CD123+ Acute Myeloid Leukemia · CD123+ Acute Myeloid Leukemia

#CD123+AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART7 cells (ThisCART7 cells)

T-Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-Acute Lymphoblastic Leukemia

#T-AcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleRuijin HospitalPhase 2

Tirelizumab (Tirelizumab)

Esophageal Squamous Cell Carcinoma · Esophageal Squamous Cell Carcinoma

#EsophagealSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleTianjin Medical University Canc…Phase 2

Tiselizumab (Tiselizumab)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBeiGenePhase 2

Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

Non-squamous Non-small Cell Lung Cancer; EGFR Gene Mutation · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleBeiGenePhase 2

Tislelizumab combined with chemotherapy (Tislelizumab combined with chemotherapy)

Rectal Cancer; Rectal Cancer Stage II · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleBeiGenePhase 2

Tislelizumab plus Bevacizumab (Tislelizumab plus Bevacizumab)

Astrocytoma of Brain · Astrocytoma of Brain

#AstrocytomaofBrain#Antibody#Phase2#항체#면역항체+2
효능 ORR 37.1%임상시험 1상태 RECRUITING
AntibodystaleBeiGenePhase 2

Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Tislelizumab; Bevacizumab · Tislelizumab

#Tislelizumab#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleBeiGenePhase 3

Tislelizumab+Oxaliplatin+Capecitabine (Tislelizumab+Oxaliplatin+Capecitabine)

Gastric Carcinoma · Gastric Carcinoma

#GastricCarcinoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBeiGenePhase 1

trastuzumab (Herceptin, Tislelizumab，atezolizumab or Trastuzumab)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE

157 / 177 페이지

← 이전다음 →